NEW · Life Sciences Tools & Services
TMO
Thermo Fisher Scientific Inc · $242.11B
654.80
+0.35%
Price
21 sessions shownTechnicals
from daily closesRSI · 14 day
67.7
Avg true range · 14d
2.47%
Volatility · 20d annualised
25.0%
Trend · 20d vs 50d
—
vs 20-day average
1.32%
vs 50-day average
—
vs 200-day average
—
200-day average
—
Internals
where it sits, and how hard it is being traded52-week low
435.27
52-week high
683.63
Volume vs its 20-day avg
—
Beta vs the market
0.86
Sitting 88% of the way up its 52-week range (435.27 → 683.63)
Fundamentals
P/E
34.76
Fwd P/E
—
P/S
5.23
P/B
4.08
EV/EBITDA
29.68
ROE
13.3%
ROA
6.3%
Gross margin
40.9%
Net margin
—
Debt / equity
0.74
Rev growth
7.2%
EPS growth
0.2%
Earnings
next report before the openNext report
Oct 21, 2026
EPS expected
6.47
Beat in last 4
4 of 4
2026-06-30reported 6.03 vs 5.77 expected+4.5%
2026-03-31reported 5.44 vs 5.29 expected+2.8%
2025-12-31reported 6.57 vs 6.51 expected+0.9%
2025-09-30reported 5.79 vs 5.55 expected+4.4%
Analyst coverage
36 analysts · as of 2026-09-01Strong buy
11
Buy
18
Hold
7
Sell
0
Strong sell
0
News
stories naming this company, last 21 daysEvery figure here is measured from live market data as of Oct 4, 05:51 PM. Nothing is estimated or filled in — where a figure shows — the source had no value for it, and a section you don’t see had no data at all. This describes what the market has already done. It is not a forecast, and not financial advice.